Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias

Abstract Background and objective Pooled analyses of previous randomized controlled trials reported that antifibrotics improved survival in patients with idiopathic pulmonary fibrosis (IPF), but the results were only based on short-term outcome data from selected patients who met strict criteria. Ob...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Hironao Hozumi, Koichi Miyashita, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-07-01
Colecção:	Respiratory Research
Assuntos:	Idiopathic pulmonary fibrosis Antifibrotics Nintedanib Pirfenidone Mortality
Acesso em linha:	https://doi.org/10.1186/s12931-024-02922-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!